Neogen Corporation Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
Neogen Corporation (NEOG) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory of $232.00 thousand as of 2022-07-01, per its 10-Q filed 2024-04-09.
Discontinued › Notes › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset › Business Combination, Recognized Asset Acquired, Asset, Current
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory · last filed 2024-04-09
- 2022-07-01: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $232.00K.
- 2020-03-26: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $164.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory |
|---|---|
| 2022-07-01 | $232.00K 10-Q · filed 2024-04-09 |
| 2020-03-26 | $164.00K 10-K · filed 2022-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |